Long-term Evaluation of a Mobile Application for Follow-up of Cardiac Patients (Cardio2U Study)
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital, Antwerp
About this trial
This trial has to aim to evaluate an innovative, in-house developed mobile application supporting patients in their home environment by actively involving them in different aspects of their condition and treatment. The usability, long-term adherence and patient satisfaction will be studied in patients with atrial fibrillation (AF) and/or heart failure (HF).
Eligibility criteria
Qualifiers
Age ≥ 18 years,
Patients in whom AF or atrial flutter is diagnosed with an electrocardiogram (12-lead, Holter monitor,…) and/or patients in whom HF is diagnosed in their medical records,
Patients who are capable of signing the informed consent.
Disqualifiers
Not able to speak and read Dutch,
Cognitive impaired (e.g. severe dementia),
No smartphone or tablet available.
Trial design
Treatments tested in this trial
- Cardio2U follow-up
Treatment groups
200 Participants
are divided into 2 treatment groupsLocations
1University Hospital Antwerp2650, EdegemAntwerp, Belgium
Sponsors and collaborators
University Hospital, Antwerp
Lead sponsor
Source ClinicalTrials.gov